Qomel Invests $1.38 Million in Kure Cells to Advance Advanced Cell Therapies
Qomel Co.’s board of directors approved, on October 12, an investment of $1.38 million in US-based biotechnology company Kure Cells, a leading firm specializing in cell therapies, regenerative medicine, and […]